Erika Rimondi
Overview
Explore the profile of Erika Rimondi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
611
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Secchiero P, Rimondi E, Marcuzzi A, Longo G, Papi C, Manfredini M, et al.
Int J Mol Sci
. 2024 Aug;
25(15).
PMID: 39125666
In recent years, the incidence of metabolic syndrome (MS) has increased due to lifestyle-related factors in developed countries. MS represents a group of conditions that increase the risk of diabetes,...
2.
Caruso L, Fields M, Rimondi E, Zauli G, Longo G, Marcuzzi A, et al.
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38396799
The human retina is a complex anatomical structure that has no regenerative capacity. The pathogenesis of most retinopathies can be attributed to inflammation, with the activation of the inflammasome protein...
3.
Maximova N, Nistico D, Riccio G, Maestro A, Barbi E, Kotnik B, et al.
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509268
The high serum concentrations of TNF-α characterize acute graft-versus-host disease (aGVHD), for which infliximab treatment may be beneficial. In 28 pediatric patients, four doses of 10 mg/kg infliximab every seven...
4.
Melloni E, Grassilli S, Romani A, Rimondi E, Marcuzzi A, Zauli E, et al.
Nutrients
. 2023 Apr;
15(7).
PMID: 37049568
(CP) is a common Indian herb, largely employed in Ayurvedic medicine and known for its neuroprotective and neuroinflammatory action. Its effectiveness against several pathologic/sub-pathologic conditions is widely accepted, but it...
5.
Squillaci D, Marcuzzi A, Rimondi E, Riccio G, Barbi E, Zanon D, et al.
Life Sci Alliance
. 2023 Mar;
6(5).
PMID: 36878639
Despite advances in acute graft-versus-host disease (aGVHD) prophylaxis, current pharmacological approaches fail to prevent aGVHD. The protective effect of defibrotide on GVHD incidence and GVHD-free survival has not been sufficiently...
6.
Fields M, Marcuzzi A, Gonelli A, Celeghini C, Maximova N, Rimondi E
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36835150
Neurodegenerative diseases comprise a wide spectrum of pathologies characterized by progressive loss of neuronal functions and structures. Despite having different genetic backgrounds and etiology, in recent years, many studies have...
7.
Casciano F, Zauli E, Rimondi E, Mura M, Previati M, Busin M, et al.
Front Med (Lausanne)
. 2022 Nov;
9:973856.
PMID: 36388931
The retina, the part of the eye, translates the light signal into an electric current that can be sent to the brain as visual information. To achieve this, the retina...
8.
Pisanti S, Rimondi E, Pozza E, Melloni E, Zauli E, Bifulco M, et al.
Int J Environ Res Public Health
. 2022 Jul;
19(15).
PMID: 35897423
The cholesterol biosynthesis represents a crucial metabolic pathway for cellular homeostasis. The end products of this pathway are sterols, such as cholesterol, which are essential components of cell membranes, precursors...
9.
Marcuzzi A, Rimondi E, Melloni E, Zennaro F, Sonzogni A, Leo S, et al.
Int J Mol Sci
. 2022 Apr;
23(7).
PMID: 35408912
Early post-transplant is the critical phase for the success of hematopoietic stem cell transplantation (HSCT). New viral infections and the reactivations associated with complete ablation of the recipient's T-cell immunity...
10.
Marcuzzi A, Rimondi E, Melloni E, Gonelli A, Grasso A, Barbi E, et al.
Pharmaceuticals (Basel)
. 2022 Mar;
15(3).
PMID: 35337171
Janus kinases (JAK) are a family of tyrosine kinases (JAK1, JAK2, JAK3, and TYK2) that transduce cytokine-mediated signals through the JAK-STAT metabolic pathway. These kinases act by regulating the transcription...